Eli Lilly and Company has agreed to acquire SiteOne Therapeutics Inc., a private biotech company developing small molecule ...

Sapio Sciences, the science-aware lab informatics platform, has promoted Gordon McCall to Chief Operating Officer (COO).

GRIN Therapeutics Inc. and Angelini Pharma have partnered for the development and commercial rights outside of North America ...

Lifecore Biomedical Inc., a fully integrated CDMO, has appointed Mark DaFonseca as its Chief Commercial Officer.

The award jury recognizes strategic and sustainable corporate management.

Hansa Biopharma AB, which appointed a new CEO and COO earlier this year, has announced plans to restructure its organization.

The development of oral dosage forms for clinical trials presents a unique set of challenges, particularly in early phases of ...

In this CEO Spotlight, Contract Pharma sits down with Nick Buschur, Chief Executive Officer of Woodstock Sterile Solutions.

Today’s pharma companies must rethink contract packaging and find partners that go beyond providing packaging services and instead enhance their manufacturing processes with flexibility and a ...

This transition reflects a planned and strategic evolution of MC2 Therapeutics, aligned with the company’s focus on commercial expansion.

The U.S. Food and Drug Administration (FDA) has approved STARJEMZA Injection, a biosimilar referencing Stelara (ustekinumab) Injection.

Waters Corp. has acquired Halo Labs, a company specialized in imaging technologies to detect, identify, and count interfering ...